Sublingual sugar for infant hypoglycaemia - Authors' reply

Affiliations

¹ University of Auckland, Liggins Institute, Auckland, New Zealand. Electronic address: j.harding@auckland.ac.nz.
² University of Auckland, Liggins Institute, Auckland, New Zealand; Newborn Intensive Care Unit, Waikato District Health Board, Hamilton, New Zealand.
³ Newborn Intensive Care Unit, Waikato District Health Board, Hamilton, New Zealand.
⁴ Mechanical Engineering Department, University of Canterbury, Christchurch, New Zealand.

Comment

Jane E Harding et al. Lancet. 2014.

. 2014 Apr 5;383(9924):1208-9.

doi: 10.1016/S0140-6736(14)60602-4.

¹ University of Auckland, Liggins Institute, Auckland, New Zealand. Electronic address: j.harding@auckland.ac.nz.
² University of Auckland, Liggins Institute, Auckland, New Zealand; Newborn Intensive Care Unit, Waikato District Health Board, Hamilton, New Zealand.
³ Newborn Intensive Care Unit, Waikato District Health Board, Hamilton, New Zealand.
⁴ Mechanical Engineering Department, University of Canterbury, Christchurch, New Zealand.

No abstract available

Comment on

Dextrose gel for neonatal hypoglycaemia (the Sugar Babies Study): a randomised, double-blind, placebo-controlled trial.
Harris DL, Weston PJ, Signal M, Chase JG, Harding JE. Harris DL, et al. Lancet. 2013 Dec 21;382(9910):2077-83. doi: 10.1016/S0140-6736(13)61645-1. Epub 2013 Sep 25. Lancet. 2013. PMID: 24075361 Clinical Trial.
Sublingual sugar for infant hypoglycaemia.
Barennes H, Willcox ML, Graz B, Pussard E. Barennes H, et al. Lancet. 2014 Apr 5;383(9924):1208. doi: 10.1016/S0140-6736(14)60601-2. Lancet. 2014. PMID: 24703563 No abstract available.